CA-LEGENDARY-ENTER
10.9.2021 18:27:10 CEST | Business Wire | Press release
Legendary Entertainment:
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210910005448/en/
What: In celebration of the Fall release of Warner Bros. Pictures and Legendary Pictures’ blockbuster film event Dune , Legendary Entertainment, in collaboration with iv gallery, Lineage Studios, and MakersPlace will present an official Dune NFT collection of digital artifacts inspired by the rich world of Denis Villeneuve’s highly anticipated film. This wide-reaching collection, packed with surprises, will include artifacts capturing humanity’s “future history”, from detailed in-world royal portraits of iconic characters taken from the hallowed halls of House Atreides and House Harkonnen to towering sculptures and artifacts unearthed from the shifting sands of Arrakis – known to its inhabitants as Dune.
The Current Dune: Future Artifacts Collection Set to Drop on September 22 features:
- Digital Sculptures – Dune’s most iconic characters, crafted in the likeness of the film’s all-star cast including two editions of Paul Atreides (Timothée Chalamet), Chani (Zendaya), Baron Vladimir Harkkonen (Stellan Skarsgård), Lady Jessica (Rebecca Ferguson), Duncan Idaho (Jason Momoa) and Duke Leto (Oscar Isaac).
- Hans Zimmer’s Dune Score – Every digital sculpture is elevated by the accompaniment of excerpts from the groundbreaking original score of world-renowned composer, Hans Zimmer.
- Spice Artwork – Fans will also have an opportunity to obtain a special limited-edition piece of art celebrating Spice, because as every Dune aficionado knows, he who controls the Spice controls the universe.
The Expanded Collection, Set to Drop in the Coming Weeks (Dates to be Announced):
The excitement of the Dune: Future Artifacts program will continue with additional drops featuring memorabilia and art meant to complete this thrilling digital museum.
Pieces to include…
- A special collection of original pieces from well-known digital artists such as Boss Logic, Matt Griffin and NFN Kalyan
- Additional digital statue sculpts
- Special in-world weaponry, including the storied crysknife
When : The collection launches on September 22nd , with additional artifacts being launched throughout the month of October.
Where : The adventure begins at http://www.dunemovie.com/futureartifacts .
Why: “This collection represents an exciting new direction in the NFT space,” said James Ngo, Executive Vice President of Franchise Management for Legendary Entertainment. “We are thrilled to have created a new collectible experience for the fandom by using exclusive assets taken directly from the film to give enthusiasts a whole new way to not only acquire film memorabilia but also further immerse themselves into the world of Dune .
ABOUT DENIS VILLENEUVE’S DUNE FILM
OSCAR® nominee Denis Villeneuve directed Warner Bros. Pictures and Legendary Pictures’ Dune . The film stars OSCAR® nominee Timothée Chalamet, Rebecca Ferguson, Oscar Isaac, OSCAR® nominee Josh Brolin, Stellan Skarsgård, Dave Bautista, Stephen McKinley Henderson, Zendaya, Chang Chen, David Dastmalchian, Sharon Duncan-Brewster, with OSCAR® nominee Charlotte Rampling, with Jason Momoa, and OSCAR® winner Javier Bardem. Villeneuve directed Dune from a screenplay by Jon Spaihts and Villeneuve and OSCAR® winner Eric Roth, based on the novel of the same name written by Frank Herbert. The film’s producers were OSCAR® nominee Mary Parent, Villeneuve, Cale Boyter and Joe Caracciolo, Jr. The executive producers were Tanya Lapointe, Joshua Grode, Herbert W. Gains, Jon Spaihts, Thomas Tull, Brian Herbert, Byron Merritt and Kim Herbert, with Kevin J. Anderson as special consultant. Warner Bros. Pictures and Legendary Pictures Present a Legendary Pictures Production, a Film by Denis Villeneuve, Dune . The film is slated to be released worldwide this fall, in theaters from 15 September internationally and in the U.S. on October 22 in both theaters and on HBO Max; it will be available on HBO Max in the Ad-Free plan for 31 days from theatrical release. The film has been rated PG-13 for sequences of strong violence, some disturbing images and suggestive material.
ABOUT HANS ZIMMER’S DUNE SCORE
Legendary composer and lifelong Dune fan Hans Zimmer has composed THREE albums of music for Warner Bros. Pictures and Legendary Pictures’ Dune . Now available is the digital album The Dune Sketchbook (Music from the Soundtrack) , which is comprised of extended, immersive musical explorations of the “Dune” film score. September 17th will see the digital album release of Dune (Original Motion Picture Soundtrack) , featuring the iconic composer’s “Dune” film score. And October 22nd is the digital release date for The Art and Soul of Dune - the companion soundtrack to the book of the same title, offering uniquely crafted versions of the film’s main themes curated by Zimmer.
ABOUT LEGENDARY ENTERTAINMENT
Legendary Entertainment is a leading media company with film (Legendary Pictures), television and digital (Legendary Television and Digital Media) and comics (Legendary Comics) divisions dedicated to owning, producing and delivering content to worldwide audiences. Legendary has built a library of marquee media properties and has established itself as a trusted brand which consistently delivers high-quality, commercial entertainment including some of the world's most popular intellectual property. In aggregate, Legendary Pictures-associated productions have realized grosses of more than $18 billion worldwide at the box office. To learn more visit: www.legendary.com .
ABOUT MAKERSPLACE
MakersPlace is the premier NFT marketplace for digital art. Launched in 2018, MakersPlace utilizes blockchain technology to facilitate the sale of authentic, original digital artwork, ensuring rarity and ownership for both creators and collectors. MakersPlace has emphasized accessibility since its inception, and has attracted a large mainstream audience as the first NFT marketplace to accept both cryptocurrency (ETH) and non-cryptocurrency (USD) payments, which it facilitates through crypto wallet and credit card transactions, respectively. MakersPlace helped catapult digital art and NFTs onto the global stage, with the historic sale of Beeple’s Everydays: The First 5000 Days for $69.3 million in partnership with Christie’s auction house in March 2021 – the record price for any digital artwork. Our mission is simple: to enable a vibrant future for digital creativity.
View source version on businesswire.com: https://www.businesswire.com/news/home/20210910005448/en/
Link:
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
International Human Rights Lawyer Jared Genser and Former White House Counsel Lanny J. Davis Join Legal and Advocacy Team Supporting Cambodian Businessman Yim Leak, Seiden Law LLP Announces18.9.2026 19:52:00 CEST | Press release
Jared Genser, one of the world's most recognized international human rights lawyers, and Lanny J. Davis, an adviser to former presidents George W. Bush and Bill Clinton, join the legal and advocacy team for Cambodian businessman Yim Leak and challenge what they call a coordinated smear campaign in Thailand. International human rights lawyer Jared Genser and Lanny J. Davis, who has close ties to two former US presidents and a worldwide reputation for defending those under attack with lies and smears, and for repairing the damage done to their reputations, have joined the legal and advocacy team supporting Cambodian businessman Yim Leak, Seiden Law LLP, which serves as Yim Leak's chief global counsel, announced today. Their first move is to hold the Thai government accountable, framing its conduct as either complicit in or willfully blind to a sustained smear campaign against Yim. Genser is Managing Director of Perseus Strategies, an international law firm. Over more than two decades, he
Ningbo FEED Meeting Confirms Full Confidence in Q1 2027 FID for Allied Biofuels’ US$6.1 Billion Presidential Decree-Backed SAF and e-SAF Project18.9.2026 17:38:00 CEST | Press release
Allied Biofuels has held a major Front-End Engineering Design (FEED) meeting at Sinopec’s office in Ningbo, China, bringing together Allied Biofuels, Sinopec Engineering Group Co., Ltd. of China, Topsoe A/S of Denmark, Sasol South Africa Limited, and Plug Power of the United States — the principal international engineering and technology providers supporting its US$6.1 billion Presidential Decree-backed Sustainable Aviation Fuel (SAF) and e-SAF project in Uzbekistan. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260918708077/en/ FEED Meeting - Ningbo, China At the joint FEED meeting of the project’s core engineering and technology stakeholders, the discussions established clear alignment on engineering responsibilities, technology interfaces, design deliverables, project integration and the coordinated execution programme required to advance the project through FEED. All stakeholders working on the project expressed full co
Corcept Announces CHMP Opinion Recommending EU Marketing Authorization for Lifyorli® (Relacorilant)18.9.2026 14:00:00 CEST | Press release
Corcept Therapeutics Incorporated (NASDAQ: CORT), a commercial-stage company engaged in the discovery and development of medications to treat severe endocrinologic, oncologic, metabolic and neurologic disorders by modulating the effects of the hormone cortisol, today announced that the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has recommended that the European Commission (EC) should approve relacorilant, combined with the chemotherapy drug nab-paclitaxel, for the treatment of patients with platinum-resistant ovarian cancer. The CHMP’s recommendation is based on positive data from Corcept’s Phase 2 and pivotal Phase 3 ROSELLA trials, in which patients receiving relacorilant combined with nab-paclitaxel experienced improved progression-free and overall survival compared to patients who received nab-paclitaxel alone. The safety profile of relacorilant plus nab-paclitaxel in these trials was consistent with the safety profile of nab-paclitaxel monoth
Enhertu® Recommended for Approval in the EU by CHMP as Adjuvant Treatment for Patients with Residual Disease After Neoadjuvant Treatment for HER2 Positive Early Breast Cancer18.9.2026 14:00:00 CEST | Press release
Recommendation based on DESTINY-Breast05 phase 3 trial results that showed Enhertu reduced the risk of invasive disease recurrence or death by 53% versus T-DM1 Daiichi Sankyo and AstraZeneca’s Enhertu has the potential to become a new standard of care in this early breast cancer setting Enhertu® (trastuzumab deruxtecan) has been recommended for approval in the European Union (EU) as a monotherapy for the adjuvant treatment of adult patients with resected HER2 positive breast cancer who have residual invasive disease after neoadjuvant taxane-based and HER2 targeted treatment. Enhertu is a specifically engineered HER2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) based its positive opinion on results from the DESTINY-Breast05 phase 3 trial presented at th
CHMP Recommends EU Approval of New Indication for Alfasigma’s Jyseleca® (filgotinib), Treatment of Adults With Axial Spondyloarthritis18.9.2026 12:58:00 CEST | Press release
The information contained within this press release is for the purpose of scientific exchange.It is intended for scientific, financial and investor media only.If approved, Jyselecawill be indicated for the treatment of patients with active axial spondyloarthritis (axSpA), both non-radiographic and radiographic forms of the disease, who have responded inadequately to conventional therapy.Despite the availability of multiple treatment options, nearly half of people living with axSpA do not respond adequately to current therapies, and just 10-20% reach inactive disease within 16-24 weeks of initiating treatment.CHMP’s positive opinion is based on findings from the OLINGUITO Phase 3 study, where improvements in the signs and symptoms of axSpA with filgotinib were observed early and maintained over 52 weeks of treatment.Jyselecais already approved in Europe and the United Kingdom, for the treatment of moderate to severe rheumatoid arthritis and ulcerative colitis. Alfasigma S.p.A, a global
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom